Published
4 years agoon
By
NewsSorrento Therapeutics of San Diego said Friday that an antibody it has been developing proved highly effective in blocking the novel coronavirus in laboratory experiments — a possible first step in the creation of a drug cocktail to battle COVID-19.
The antibody, known as STI-1499, performed well even though it was used at a concentration 10- to 100-fold lower than antibodies used to treat other diseases, the company said.
STI-1499 is one of more than a billion antibodies that Sorrento Therapeutics has been examining in an effort to find an effective treatment against a virus that has killed more than 85,000 people in the U.S.
By Gary Robbins and Jonathan Wosen | 15 May 2020
Fresno Pacific Classes Back Online Because of Omicron Surge
Fresno, Kern Residents Win $50K Each in Vaccination Lottery
The Latest: Germany Reports 24,000 Daily Coronavirus Cases
‘Tip of the Iceberg’ : More Dangerous Virus Variant Confirmed in 3 Fresno County Patients.
Local Schools Leader Says New COVID 3-Foot Desk Rule is ‘Game Changer’
Opinion: Legislative Staff Right to Unionize: What Could Go Wrong?